News MDMA-assisted therapy significantly reduces moderate to severe PTSD symptoms The study findings represent the culmination of more than two decades of dedicated research efforts Natalia Buendia CalvilloSeptember 15, 2023
Psychedelics Sweden’s Norrsken Foundation launches $4.4M psychedelics mental health initiative Funds will be used to study psilocybin and MDMA-assisted therapy; non-profit says Sweden needs to 'catch up' in this area of research Rowan DunneSeptember 14, 2023
News Silo Pharma to test a novel experimental intranasal formulation for PTSD Silo's SPC-15 was developed in collaboration with Columbia University Natalia Buendia CalvilloSeptember 13, 2023
News Lucy Scientific acquires BlueSky Wellness portfolio of brands Lucy expects to complete the acquisition within 90 days Natalia Buendia CalvilloSeptember 12, 2023
Psychedelics AI shows potential for predicting psilocybin therapy outcomes: COMPASS study The paper in the journal Psychopharmacology concluded that a machine learning algorithm could predict treatment efficacy Rowan DunneSeptember 8, 2023
News Clearmind to collaborate with Johns Hopkins University to study promising psychedelic treatment for alcohol use disorder Johns Hopkins University School of Medicine is the second U.S. clinical site to join Clearmind's trial, following Yale School of Medicine's psychiatry department Natalia Buendia CalvilloSeptember 6, 2023
Psychedelics PharmAla Biotech lists on the OTCQB middle-tier venture market The MDMA producer is now trading under the symbol PMBHF, which is intended to attract more investors in the U.S. Rowan DunneSeptember 6, 2023
Psychedelics Otsuka Pharmaceutical seals $80M all-cash deal to acquire Mindset Pharma Mindset shareholders will receive $0.75 in cash for each share, representing a premium based on various trading metrics Natalia Buendia CalvilloAugust 31, 2023
News Silo Wellness to acquire NUGL/Kaya Group in a $43.3M deal Silo Wellness will acquire all of NUGL's issued and outstanding shares in exchange for 2 million shares from its treasury Natalia Buendia CalvilloAugust 30, 2023
Psychedelics Cybin inks agreement to acquire DMT drug developer Small Pharma The companies say they will have the most substantial dataset on the DMT molecule in the industry and largest IP portfolio Rowan DunneAugust 28, 2023